Showing results (31-40 of 106) with videos related to
Sort By:
Pageof 11
Biomolecules|September 27, 2025
Interaction Between Heparan Sulfate Oligosaccharide and the Receptor-Binding Domain of the Wild-Type and Omicron Variant of the SARS-CoV-2 Spike ProteinMarco Mandalari, Michela Parafioriti, Minghong Ni, et al.The Journal of Biological Chemistry|March 12, 2005
Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanaseFlonia Levy-Adam, Ghada Abboud-Jarrous, Marco Guerrini, et al.Frontiers in Medicine|May 7, 2019
SAX-HPLC and HSQC NMR Spectroscopy: Orthogonal Methods for Characterizing Heparin Batches CompositionFranco Spelta, Lino Liverani, Alessandra Peluso, et al.Thrombosis and Haemostasis|November 6, 2009
The tainted heparin story: an updateMarco Guerrini, Zachary Shriver, Antonella Bisio, et al.Seminars in Thrombosis and Hemostasis|September 24, 2002
Low-molecular-weight heparin and dermatan sulfate end group-labeled with tyramine and fluorescein. Biochemical and biological characterization of the fluorescent-labeled heparin derivativeJob Harenberg, Benito Casu, Marco Guerrini, et al.Thrombosis and Haemostasis|February 6, 2010
Low-molecular-weight heparin from Cu2+ and Fe2+ Fenton type depolymerisation processesElena Vismara, Monica Pierini, Giuseppe Mascellani, et al.Molecules (Basel, Switzerland)|July 6, 2017
Characterization of Danaparoid Complex Extractive Drug by an Orthogonal Analytical ApproachCristina Gardini, Elena Urso, Marco Guerrini, et al.Analytical Chemistry|December 18, 2012
Characterizing the microstructure of heparin and heparan sulfate using N-sulfoglucosamine 1H and 15N NMR chemical shift analysisDerek J Langeslay, Consuelo N Beecher, Annamaria Naggi, et al.Glycobiology|July 28, 2018
Structural and conformational studies of the heparan sulfate mimetic PI-88Stefano Elli, Eduardo Stancanelli, Paul N Handley, et al.Glycobiology|June 29, 2010
Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycanStéphane Sarrazin, Malcolm Lyon, Jon A Deakin, et al.Pageof 11